Latest news
PD-L1–high metastatic TNBC: Pembrolizumab plus chemotherapy performs in practice - Vera HealthVera Health · Sat, 01 Aug 2026 04:39:46 GMTAZTEC Trial Finds SABR Schedules Do Not Meet PFS Benchmark With Atezolizumab in Advanced TNBC - Pharmacy TimesPharmacy Times · Thu, 30 Jul 2026 20:48:18 GMTKelun-Biotech's Sac-TMT Gains NMPA Review for First-Line Advanced TNBC Indication - BioPharm InternationalBioPharm International · Thu, 30 Jul 2026 17:19:38 GMT